Compare Mesoblast Limited (MESO) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Public Storage — how do they compare? Mesoblast Limited trades at $16.8 (market cap $2.21B), while Public Storage trades at $325.32 (market cap $60.71B). The key difference: Public Storage is far larger — about 27.5× Mesoblast Limited's market cap, and Public Storage pays a 3.69% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | PSA | |
|---|---|---|
Market Cap | $2.21B | $60.71B |
Sector | Technology | Real Estate |
52-Week High | $20.96 | $330.47 |
52-Week Low | $12.88 | $258.44 |
Enterprise Value | $2.21B | $74.98B |
Dividend Yield | — | 3.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.82, up 0.84% with bullish technical signals from moving averages. The company shows strong revenue growth with Ryoncil generating $115M in its first year, but remains unprofitable with a -144.33% net income margin. Recent developments include positive Phase 3 trial progress and BLA filing for heart failure treatment, supported by analyst consensus leaning bullish with 45% buy ratings.
MESO presents a high-risk, high-reward opportunity with promising commercial traction offset by significant losses. Investment thesis hinges on successful pipeline development and profitability turnaround, while risks include clinical trial outcomes, regulatory approvals, and sustained cash burn requiring careful monitoring of execution milestones.
Public Storage (PSA) trades at $325.88, up 0.05% on the day, with a neutral technical signal and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.55 exceeding expectations, and raised full-year 2026 guidance. Recent acquisitions, including National Storage Affiliates, support growth, while a $3.00 quarterly dividend underscores financial health.
Outlook remains positive with a consensus price target of $333.88, though high valuation ratios and mixed analyst sentiment pose risks. Key opportunities include expansion and dividend stability, while risks involve competitive pressures and interest rate sensitivity. The stock offers steady income but requires monitoring of operational execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
